CanniMed Therapeutics Inc. says it has entered right into a definitive settlement with PharmaChoice to supply natural, oils and oil spinoff hashish products to its greater than 750 pharmacy places throughout Canada.
It is the second one such deal introduced this week, after Aphria Inc. introduced it has entered a 5-12 months settlement to supply pharmacy chain Shoppers Drug Mart with scientific hashish.
Saskatoon-based CanniMed says PharmaChoice has dedicated to have it as sole provider of hashish products, topic to CanniMed assembly sure product and quantity necessities.
Earlier this 12 months, CanniMed signed a letter of intent with member-owned co-operative PharmaChoice to be its unique scientific hashish distributor and to teach its pharmacists and pharmacy technicians.
The corporate says its maintain PharmaChoice continues to be conditional on Health Canada’s approval of scientific hashish product distribution thru pharmacies.
CanniMed’s supply settlement comes an afternoon after it used to be notified that the Toronto Stock Exchange will defer attention of a shareholder rights plan followed through the corporate in a bid to protect itself towards a adverse takeover be offering through Aurora Cannabis Inc.
The rights plan prevents Vancouver-headquartered Aurora from obtaining any CanniMed stocks as opposed to the ones tendered to its adverse bid or from coming into into any lock-up agreements as opposed to the ones it has already signed and filed, CanniMed has stated.